HM Payson & Co
- SEC CIK
- 0000928052
- Latest filing
- Jul 17, 2026
TXT holding history
Textron Inc in every 13F filed by HM Payson & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TXT overviewAll 13F holders of TXTFull Q2 2026 holdings
- Shares (Q2 2026)
- 670
- Value
- $61.5K
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 670 | $61.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 670 | $58.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 670 | $58.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 670 | $56.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 670 | $53.8K | <0.1% | −25−3.6% | Reduced | Holders |
| Q1 2025 | 695 | $50.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 695 | $53.2K | <0.1% | −32−4.4% | Reduced | Holders |
| Q3 2024 | 727 | $64.4K | <0.1% | +31+4.5% | Added | Holders |
| Q2 2024 | 696 | $59.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 696 | $66.8K | <0.1% | +32+4.8% | Added | Holders |
| Q4 2023 | 664 | $53.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 664 | $51.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 664 | $44.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 664 | $46.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 664 | $47.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 664 | $39.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 664 | $41.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 664 | $49.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 664 | $51.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 664 | $46.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 664 | $46.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 664 | $37.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.